Exploratory Analyses of Circulating Neoplastic-Immune Hybrid Cells as Prognostic Biomarkers in Advanced Intrahepatic Cholangiocarcinoma
RK Patel, MS Parappilly, BS Walker… - … journal of molecular …, 2024 - pmc.ncbi.nlm.nih.gov
Existing clinical biomarkers do not reliably predict treatment response or disease
progression in patients with advanced intrahepatic cholangiocarcinoma (ICC). Circulating …
progression in patients with advanced intrahepatic cholangiocarcinoma (ICC). Circulating …
Management of Localized Intrahepatic Cholangiocarcinoma: What Exactly is the 'Evidence'?
LM Ocuin - Annals of Surgical Oncology, 2024 - Springer
The incidence of intrahepatic cholangiocarcinoma (ICC) is rising but it remains a relatively
rare disease, accounting for approximately 3% of all gastrointestinal cancers. 1, 2 Most …
rare disease, accounting for approximately 3% of all gastrointestinal cancers. 1, 2 Most …